Have any questions?
+44 1234 567 890
Thanks to osteolabs, doctors identify even the smallest changes in the bone structure
The laboratory test complements the previous DXA diagnostic procedure (X-ray). There is no further radiation exposure for patients. After a short time (days to weeks), the effectiveness of the therapy can be measured. There is no significant additional work in the doctor's office, as blood and urine are taken in the laboratory. The test is unique worldwide, scientifically sound and medically confirmed.
Maximum transparency thanks to studies and publications
2020: Early effects of androgen deprivation on bone and mineral homeostasis in adult men: a prospective cohort study.
2019: Bone Reports Calcium isotope ratios in blood and urine: A new biomarker for the diagnosis of osteoporosis.
2019:Anwendung von Calciumisotopenfraktionierungen zur Diagnostik der Osteoporose.
2016: Biological fractionation of stable Ca isotopes in Göttingen minipigs as a physiological model for Ca homeostasis in humans. Isotopes in Environmental and Health Studies http://www.tandfonline.com/loi/gieh20.
2010: Bone 46 (2010) 889: A pilot study on the use of natural calcium isotope (44Ca/40Ca) fractionation in urine as a proxy for the human body calcium balance.
osteolabs in practice - case study of a Kiel gynaecologist
Gynaecologist Bettina Wihlfahrt from Kiel has been using the osteolabs test procedure for some time. She reports here on a real case from her everyday practice. The patient agreed to the description of her case. The first test according to osteolabs took place on 31.3.2017. The first figure shows the results after evaluation of the blood (CID blood = -1.23). The broken orange line shows the CID threshold for osteoporosis. At the doctor's discretion, the patient was given Estramon Conti 30/95 from 21.08.2018 (green dot, labelled "Intervention").
Abb. 1
At the doctor's discretion, the patient was administered Estramon Conti 30/95 from 21.08.2018, see green dot, labelled "Intervention".
Abb. 2
Results after evaluation of blood (CIDBlood= -0.25) after medication.
In both graphs, the value from 31.03.2017 is at the bottom left, indicating severe osteoporosis corresponding to a DXA-T value of well below -2.5. Gynaecologist Bettina Wihlfahrt intervened with the patient from 21.08.2018 with a hormone treatment using Estramon Conti 30/95 and used another finding parameter of the OsteoTest | med from osteolabs: elemental calcium. This is additionally measured in the urine with the OsteoTest | med.
Abb. 3
After initiating the therapy, the elemental Ca level in the urine becomes similar to the average for postmenopausal women. This means that less Ca is excreted than before the start of therapy and more Ca remains in the patient's body, which can be used again to build up the bones.
With the OsteoTest | med from osteolabs, gynaecologist Wihlfahrt was able to visualise that her patient's CID values had already risen to the age-appropriate mean value of healthy postmenopausal women eight days after intervention. The test from 29.08.2018 shows the significantly higher CID blood levels (by about -0.9 and CID urine levels by 0.1). The changes in calcium absorption after the medical intervention can be traced in the patient's urine calcium concentration. After the start of treatment on 21.08.2018, the urine calcium concentration almost halved from initially about 170 mg/l to about 90 mg/l. This is due to the reduced Ca absorption caused by the medication.
The gynaecologist had all the samples taken in her own practice laboratory by her medical assistants and received the corresponding findings from the Kiel laboratory of Dr. Krause & colleagues. The osteoporosis test by osteolabs confirmed the success of the treatment:
The medication administered has demonstrably led to a significant improvement in calcium absorption in the bones.
Mrs Wihlfahrt's opinion:
"My patient was able to return to her old job. For me, the patient is always in the foreground, even when choosing the measurement method. In this case, the test from osteolabs offered good possibilities before and during the therapy: I was able to assess which therapy was the right one for my patient after a very short time. And I was able to control the medication well, for the benefit of my patient."
The procedure in your practice
Order free sampling set
Collect urine & blood sample from patient
Sending the samples to the osteolabs
Get result report from the lab
Discussion of the results with the patient
Become a partner physician- free of charge and without obligation
Since osteolabs is still little known, we offer partner doctors throughout Germany the opportunity to offer it to their patients beyond early detection as a procedure for therapy support. We will make sure that you become an expert in this new test procedure. In addition, you will become a member of the expert pool and thus a proven expert and user of the new procedure for the early detection and treatment of osteoporosis.
